Open-Label, Fixed-Sequence, Crossover Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2011
At a glance
- Drugs Fosamprenavir; Maraviroc; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 14 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Oct 2010 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.